Skip directly to search Skip directly to site content

Podcasts at CDC

CDC A-Z Index

  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
  27. #

Text Size:

Podcast Header CDC Podcast list Podcast Help CDC RSS Feeds RSS Help
Download CDC podcasts to your desktop and portable music/video player for health information at your convenience and on the go. New to podcasting? See Podcast Help and RSS Help

Browse By Topic Hepatitis B Vaccination

Vaccinating newborns with the hepatitis B vaccine is important. In the United States, approximately ninety percent of hepatitis B infections can be prevented in newborns if the hepatitis B vaccine is administered shortly after birth.    

Don’t Leave the Hospital Without It
Listen to the podcast Listen To This Podcast... (3:23) (A Cup of Health with CDC)


Vaccinating newborns with the hepatitis B vaccine is important. In the United States, approximately ninety percent of hepatitis B infections can be prevented in newborns if the hepatitis B vaccine is administered shortly after birth.  (Created: 8/1/2008 by MMWR)
Date Released: 7/31/2008

This broadcast discusses the importance of newborns receiving the hepatitis B vaccine shortly after birth.    

Don’t Leave the Hospital Without It
Listen to the podcast Listen To This Podcast... (0:59) (A Minute of Health with CDC)


This broadcast discusses the importance of newborns receiving the hepatitis B vaccine shortly after birth.  (Created: 8/1/2008 by MMWR)
Date Released: 7/31/2008

This podcast discusses an underappreciated health threat to many Asians and Pacific Islanders in the United States: chronic infection with the hepatitis B virus. Dr. John Ward, director of CDC's Division of Viral Hepatitis, and Dr. Sam So, founder of the Asian Liver Center at Stanford University, address the importance of testing, vaccination, and care to prevent serious health consequences from this     

Stopping the Silent Killer: Hepatitis B Among Asian Americans
Listen to the podcast Listen To This Podcast... (6:22)


This podcast discusses an underappreciated health threat to many Asians and Pacific Islanders in the United States: chronic infection with the hepatitis B virus. Dr. John Ward, director of CDC's Division of Viral Hepatitis, and Dr. Sam So, founder of the Asian Liver Center at Stanford University, address the importance of testing, vaccination, and care to prevent serious health consequences from this "silent" disease.  (Created: 4/18/2008 by National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP), Division of Viral Hepatitis (DVH) and Office of Dispute Resolution and Equal Employment Opportunity, Office of the Director (OD) )
Date Released: 5/1/2008

Los virus de la hepatitis aguda A, B y C son objeto de una vigilancia epidemiológica nacional.  Entre 1995 y 2005, las tasas de hepatitis aguda por estos tres tipos de virus disminuyeron en forma drástica. Esta reducción fue una de las consecuencias de la implementación de estrategias de prevención globales para cada enfermedad, entre las que se incluye la disponibilidad de vacunas eficaces contra las hepatitis A y B.     

El “ABC” de la hepatitis
Listen to the podcast Listen To This Podcast... (1:24)


Los virus de la hepatitis aguda A, B y C son objeto de una vigilancia epidemiológica nacional. Entre 1995 y 2005, las tasas de hepatitis aguda por estos tres tipos de virus disminuyeron en forma drástica. Esta reducción fue una de las consecuencias de la implementación de estrategias de prevención globales para cada enfermedad, entre las que se incluye la disponibilidad de vacunas eficaces contra las hepatitis A y B.   (Created: 3/2/2007 by MMWR)
Date Released: 1/18/2008

National surveillance is conducted for acute hepatitis A, B, and C viruses. During 1995--2005, rates of all three types of acute viral hepatitis declined dramatically. These declines partially resulted from implementation of comprehensive prevention strategies for each disease, including the introduction of effective vaccines against hepatitis A and hepatitis B.    

The ABCs of Hepatitis
Listen to the podcast Listen To This Podcast... (9:34) (A Cup of Health with CDC)


National surveillance is conducted for acute hepatitis A, B, and C viruses. During 1995--2005, rates of all three types of acute viral hepatitis declined dramatically. These declines partially resulted from implementation of comprehensive prevention strategies for each disease, including the introduction of effective vaccines against hepatitis A and hepatitis B.  (Created: 3/2/2007 by MMWR)
Date Released: 8/10/2007

National surveillance is conducted for acute hepatitis A, B, and C viruses. During 1995--2005, rates of all three types of acute viral hepatitis declined dramatically. These declines partially resulted from implementation of comprehensive prevention strategies for each disease, including the introduction of effective vaccines against hepatitis A and hepatitis B.    

The ABCs of Hepatitis
Listen to the podcast Listen To This Podcast... (0:59) (A Minute of Health with CDC)


National surveillance is conducted for acute hepatitis A, B, and C viruses. During 1995--2005, rates of all three types of acute viral hepatitis declined dramatically. These declines partially resulted from implementation of comprehensive prevention strategies for each disease, including the introduction of effective vaccines against hepatitis A and hepatitis B.  (Created: 3/2/2007 by MMWR)
Date Released: 8/10/2007

La vacunación contra la hepatitis B es la medida más eficaz para prevenir una infección con el virus de la hepatitis B (VHB) y sus consecuencias, incluyendo cirrosis del hígado, cáncer de hígado, insuficiencia hepática y la muerte. Este informe representa la segunda y última parte de una declaración del Comité Asesor de Prácticas de Inmunización (ACIP, por sus siglas en inglés) y proporciona recomendaciones actualizadas a fin de aumentar la tasa de vacunación contra la hepatitis B en los adultos en mayor riesgo de infección por VHB.    

Estrategia integral de inmunización para eliminar la transmisión de VHB en los Estados Unidos
Listen to the podcast Listen To This Podcast... (1:01)


La vacunación contra la hepatitis B es la medida más eficaz para prevenir una infección con el virus de la hepatitis B (VHB) y sus consecuencias, incluyendo cirrosis del hígado, cáncer de hígado, insuficiencia hepática y la muerte. Este informe representa la segunda y última parte de una declaración del Comité Asesor de Prácticas de Inmunización (ACIP, por sus siglas en inglés) y proporciona recomendaciones actualizadas a fin de aumentar la tasa de vacunación contra la hepatitis B en los adultos en mayor riesgo de infección por VHB.  (Created: 4/5/2007 by MMWR)
Date Released: 4/6/2007

Hepatitis B vaccination is the most effective measure to prevent hepatitis B virus (HBV) infection and its consequences, including cirrhosis of the liver, liver cancer, liver failure, and death. This report, the second of a two-part statement from the Advisory Committee on Immunization Practices (ACIP), provides updated recommendations to increase hepatitis B vaccination of adults at risk for HBV infection.    

A Comprehensive Immunization Strategy to Eliminate Transmission of Hepatitis B Virus Infection in the United States
Listen to the podcast Listen To This Podcast... (7:56) (A Cup of Health with CDC)


Hepatitis B vaccination is the most effective measure to prevent hepatitis B virus (HBV) infection and its consequences, including cirrhosis of the liver, liver cancer, liver failure, and death. This report, the second of a two-part statement from the Advisory Committee on Immunization Practices (ACIP), provides updated recommendations to increase hepatitis B vaccination of adults at risk for HBV infection.  (Created: 12/8/2006 by MMWR)
Date Released: 12/15/2006

Hepatitis B vaccination is the most effective measure to prevent hepatitis B virus (HBV) infection and its consequences, including cirrhosis of the liver, liver cancer, liver failure, and death. This report, the second of a two-part statement from the Advisory Committee on Immunization Practices (ACIP), provides updated recommendations to increase hepatitis B vaccination of adults at risk for HBV infection.    

A Comprehensive Immunization Strategy to Eliminate Transmission of Hepatitis B Virus Infection in the United States
Listen to the podcast Listen To This Podcast... (1:20) (A Minute of Health with CDC)


Hepatitis B vaccination is the most effective measure to prevent hepatitis B virus (HBV) infection and its consequences, including cirrhosis of the liver, liver cancer, liver failure, and death. This report, the second of a two-part statement from the Advisory Committee on Immunization Practices (ACIP), provides updated recommendations to increase hepatitis B vaccination of adults at risk for HBV infection.  (Created: 12/8/2006 by MMWR)
Date Released: 12/15/2006

  Page last modified August 8, 2007

Safer, Healthier People
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348, 24 Hours/Every Day - cdcinfo@cdc.gov